For more than 15 years, there have been many attempts to expand catheter tricuspid valve upgrades. Despite intense efforts, there is no commercial generation or transparent solution that has been widely followed in the clinical community. Trillium ™ presents a unique and exclusive technical solution for the functional upgrade of the tricuspid valve. This technique gently overcomes the main obstacles to replacing the classic valve by avoiding the local tricuspid valve as the insertion site. Instead, the tubular and symmetrical vena cava act as fixation sites, allowing the Trillium to ™ to function alongside the local broken valve that upgrades it.
Amir Danino, founder and CEO, said: “Over the past decade, structural cardiac interventions have been incredibly complex and risky. This manifests itself, among other things, through the duration of those procedures and their sub-seventh rates of technical good fortune. “
View multimedia download content: https://www. prnewswire. com/news-releases/israeli-medical-device-startup-innoventric-ltd-wins-the-prestigious-horizon-europe-grant-and-secures-us – 14 million-in-series-one-investment-301412953. html
SOURCE Innoventrique